When it comes to dose design and drug development, one size doesn’t fit all. At AustinPx, every formulation strategy is built around your molecule, your patient, and your goals.
As a sponsor-informed CDMO, AustinPx was founded on the belief that the right partnership accelerates innovation. We combine advanced science, clinical insight, and flexible manufacturing to help innovators overcome development barriers—faster and smarter.
Our team works side-by-side with you to gather and interpret the data that guides confident decisions at every stage of development. From discovery through scale-up, we’re committed to helping you build your solution—not just a product.
Our Expertise and Capabilities Include:
Join Us at DCAT Week 2026
New York City | March 23-26 at the New York Hilton, Midtown Manahattan
Discover how AustinPx’s sponsor-informed CDMO model helps innovators:
- Overcome molecular formulation challenges
- Accelerate development and scale-up
- Move quickly and confidently from molecule to clinic
Meet with AustinPx Chief Scientific Officer (CSO) Dave Miller, PhD and Executive Director Rob Rigney during Biotech Showcase to learn how we can help advance your pharmaceutical product pipeline. Meetings will be conducted at The Residence Inn by Marriott New York Manhattan/Times Square located at 1033 Avenue of Americas, New York, NY 10018.
Featured Expert Content
To review more Expert Content, please visit the AustinPx Knowledge Center.
Ready to Build?
Schedule a meeting with our team to see how AustinPx can help you move from molecule to market—efficiently and confidently.